Cover

Medical Genetics in the Clinical Practice of ORL

Editor(s): Alford R.L. (Houston, Tex.) 
Sutton V.R. (Houston, Tex.) 
Table of Contents
Vol. 70, 2011
Section title: Paper
Alford RL, Sutton VR (eds): Medical Genetics in the Clinical Practice of ORL. Adv Otorhinolaryngol. Basel, Karger, 2011, vol 70, pp 43–49
(DOI:10.1159/000322469)

Hereditary Hearing Loss with Thyroid Abnormalities

Choi B.Y. · Muskett J. · King K.A. · Zalewski C.K. · Shawker T. · Reynolds J.C. · Butman J.A. · Brewer C.C. · Stewart A.K. · Alper S.L. · Griffith A.J.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Mutations in SLC26A4 can cause deafness and goiter in Pendred syndrome (PDS) or isolated non-syndromic enlargement of the vestibular aqueduct (NSEVA). PDS is one of the most common hereditary causes of deafness. It is characterized by autosomal-recessive inheritance of sensorineural hearing loss, enlarged vestibular aqueducts (EVA), and an iodide organification defect with or without goiter. The diagnosis is confirmed by detection of two mutant alleles of SLC26A4 in a patient with EVA. The perchlorate discharge test can detect the underlying thyroid biochemical defect and is useful for the evaluation of goiter or for the clinical diagnosis of PDS in a patient with a non-diagnostic SLC26A4 genotype. SLC26A4 encodes the pendrin polypeptide, an anion exchanger that, in recombinant expression systems, transports chloride, bicarbonate, and iodide. Investigation of pendrin function in the inner ear has been facilitated by the Slc26a4Δ (knockout) mouse model, but the exact mechanism of its hearing loss remains unclear, as does pendrin’s principal transport function in the inner ear. Treatment of PDS is focused upon rehabilitation of hearing loss, and surveillance and management of goiter and, less commonly, hypothyroidism.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Brucker-Davis F Skarulis MC Pikus A Ishizawar D Mastroianni MA Koby M Weintraub BD: Prevalence and mechanisms of hearing loss in patients with resistance to thyroid hormone. J Clin Endocrinol Metab 1996;81:2768-2772
  2. Pendred V: Deaf-mutism and goitre. Lancet 1896;ii:532
  3. Morgans ME Trotter WR: Association of congenital deafness with goitre; the nature of the thyroid defect. Lancet 1958;i:607-609
  4. Phelps PD Coffey RA Trembath RC, et al: Radiological malformations of the ear in Pendred syndrome. Clin Radiol 1998;53:268-273
  5. Fraser GR: Association of congenital deafness with goitre (Pendred’s syndrome) a study of 207 families. Ann Hum Genet 1965;28:201-249
  6. Everett LA Glaser B Beck JC, et al: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat Genet 1997;17:411-422
  7. Li XC Everett LA Lalwani AK Desmukh D Friedman TB Green ED Wilcox ER: A mutation in PDS causes non-syndromic recessive deafness. Nat Genet 1998;18:215-217
  8. Usami S Abe S Weston MD Shinkawa H Van Camp G Kimberling WJ: Non-syndromic hearing loss associated with enlarged vestibular aqueduct is caused by PDS mutations. Hum Genet 1999;104:188-192
  9. Pryor SP Madeo AC Reynolds JC, et al: SLC26A4/PDS genotype-phenotype correlation in hearing loss with enlargement of the vestibular aqueduct (EVA): evidence that Pendred syndrome and non-syndromic EVA are distinct clinical and genetic entities. J Med Genet 2005;42:159-165
  10. Albert S Blons H Jonard L, et al: SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur J Hum Genet 2006;14:773-779
  11. Birkenhager R Zimmer AJ Maier W Klenzner T Aschendorff A Schipper J: Evidence of a novel gene for the LAV-syndrome. Laryngo-Rhino-Otologie 2007;86:102-106
  12. Choi BY Madeo AC King KA Zalewski CK Pryor SP Muskett JA Nance WE Butman JA Brewer CC Griffith AJ: Segregation of enlarged vestibular aqueducts in families with non-diagnostic SLC26A4 genotypes. J Med Genet 2009;46:856-861
  13. Anwar S Riazuddin S Ahmed ZM Tasneem S Ateeq ul J Khan SY Griffith AJ Friedman TB Riazuddin S: SLC26A4 mutation spectrum associated with DFNB4 deafness and Pendred’s syndrome in Pakistanis. J Hum Genet 2009;54:266-270
  14. Fraser GR: Deafness with goiter (Pendred’s syndrome). Baltimore, Johns Hopkins University Press, 1976;
  15. Park HJ Shaukat S Liu XZ, et al: Origins and frequencies of SLC26A4 (PDS) mutations in east and south Asians: global implications for the epidemiology of deafness. J Med Genet 2003;40:242-248
  16. Stinckens C Huygen PL Joosten FB Van Camp G Otten B Cremers CW: Fluctuant, progressive hearing loss associated with Meniere like vertigo in three patients with the Pendred syndrome. Int J Pediatr Otorhinolaryngol 2001;61:207-215
  17. Valvassori GE Clemis JD: The large vestibular aqueduct syndrome. Laryngoscope 1978;88:723-728
  18. Govaerts PJ Casselman J Daemers K De Ceulaer G Somers T Offeciers FE: Audiological findings in large vestibular aqueduct syndrome. Int J Pediatr Otorhinolaryngol 1999;51:157-164
  19. Nakashima T Ueda H Furuhashi A Sato E Asahi K Naganawa S Beppu R: Air-bone gap and resonant frequency in large vestibular aqueduct syndrome. Am J Otol 2000;21:671-674
  20. Arjmand EM Webber A: Audiometric findings in children with a large vestibular aqueduct. Arch Otolaryngol Head Neck Surg 2004;130:1169-1174
  21. Merchant SN Nakajima HH Halpin C Nadol JB Jr Lee DJ Innis WP Curtin H Rosowski JJ: Clinical investigation and mechanism of air-bone gaps in large vestibular aqueduct syndrome. Ann Otol Rhinol Laryngol 2007;116:532-541
  22. King KA Choi BY Zalewski C, et al: SLC26A4 genotype, but not cochlear radiologic structure, is correlated with hearing loss in ears with an enlarged vestibular aqueduct. Laryngoscope 2010;120:384-389
  23. Zhou G Gopen Q Kenna MA: Delineating the hearing loss in children with enlarged vestibular aqueduct. Laryngoscope 2008;118:2062-2066
  24. Hvidberg- Hansen J Jorgensen MB: The inner ear in Pendred’s syndrome. Acta Oto-Laryngol 1968;66:129-135
  25. Choi BY Stewart AK Nishimura KK, et al: Efficient molecular genetic diagnosis of enlarged vestibular aqueducts in East Asians. Genet Testing Mol Biomarkers 2009;13:679-687
  26. Colvin IB Beale T Harrop-Griffiths K: Long-term follow-up of hearing loss in children and young adults with enlarged vestibular aqueducts: relationship to radiologic findings and Pendred syndrome diagnosis. Laryngoscope 2006;116:2027-2036
  27. Reardon W Coffey R Phelps PD Luxon LM Stephens D Kendall-Taylor P Britton KE Grossman A Trembath R: Pendred syndrome - 100 years of under-ascertainment?. Q J Med 1997;90:443-447
  28. Madeo AC Manichaikul A Reynolds JC Sarlis NJ Pryor SP Shawker TH Griffith AJ: Evaluation of the thyroid in patients with hearing loss and enlarged vestibular aqueducts. Arch Otolaryngol Head Neck Surg 2009;135:670-676
  29. Reardon W Coffey R Chowdhury T Grossman A Jan H Britton K Kendall-Taylor P Trembath R: Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome. J Med Genet 1999;36:595-598
  30. Johnsen T Larsen C Friis J Hougaard-Jensen F: Pendred’s syndrome: acoustic, vestibular and radiological findings in 17 unrelated patients. J Laryngol Otol 1987;101:1187-1192
  31. Choi BY Stewart AK Madeo AC, et al: Hypo-functional SLC26A4 variants associated with nonsyndromic hearing loss and enlargement of the vestibular aqueduct: genotype-phenotype correlation or coincidental polymorphisms?. Hum Mutat 2009;30:599-608
  32. Scott DA Wang R Kreman TM Sheffield VC Karniski LP: The Pendred syndrome gene encodes a chlorideiodide transport protein. Nat Genet 1999;21:440-443
  33. Scott DA Karniski LP: Human pendrin expressed in Xenopus laevis oocytes mediates chloride/formate exchange. Am J Physiol 2000;278:C207-C211
  34. Royaux IE Wall SM Karniski LP Everett LA Suzuki K Knepper MA Green ED: Pendrin, encoded by the Pendred syndrome gene, resides in the apical region of renal intercalated cells and mediates bicarbonate secretion. Proc Natl Acad Sci USA 2001;98:4221-4226
  35. Gillam MP Sidhaye AR Lee EJ Rutishauser J Stephan CW Kopp P: Functional characterization of pendrin in a polarized cell system: evidence for pendrin-mediated apical iodide efflux. J Biol Chem 2004;279:13004-13010
  36. Royaux IE Belyantseva IA Wu T Kachar B Everett LA Marcus DC Green ED: Localization and functional studies of pendrin in the mouse inner ear provide insight about the etiology of deafness in pendred syndrome. J Assoc Res Otolaryngol 2003;4:394-404
  37. Everett LA Belyantseva IA Noben-Trauth K Cantos R Chen A Thakkar SI Hoogstraten-Miller SL Kachar B Wu DK Green ED: Targeted disruption of mouse PDS provides insight about the inner-ear defects encountered in Pendred syndrome. Hum Mol Genet 2001;10:153-161
  38. Jabba SV Oelke A Singh R Maganti RJ Fleming S Wall SM Everett LA Green ED Wangemann P: Macrophage invasion contributes to degeneration of stria vascularis in Pendred syndrome mouse model. BMC Med 2006;4:37
  39. Wangemann P Nakaya K Wu T Maganti RJ Itza EM Sanneman JD Harbidge DG Billings S Marcus DC: Loss of cochlear HCO-3 secretion causes deafness via endolymphatic acidification and inhibition of Ca2+ reabsorption in a Pendred syndrome mouse model. Am J Physiol Renal Physiol 2007;292:F1345-F1353
  40. Singh R Wangemann P: Free radical stress-mediated loss of Kcnj10 protein expression in stria vascularis contributes to deafness in Pendred syndrome mouse model. Am J Physiol Renal Physiol 2008;294:F139-F148
  41. Wangemann P Kim HM Billings S Nakaya K Li X Singh R Sharlin DS Forrest D Marcus DC Fong P: Developmental delays consistent with cochlear hypothyroidism contribute to failure to develop hearing in mice lacking Slc26a4/pendrin expression. Am J Physiol Renal Physiol 2009;297:F1435-F1447
  42. Dai P Stewart AK Chebib F, et al: Distinct and novel SLC26A4/Pendrin mutations in Chinese and US patients with nonsyndromic hearing loss. Physiol Genom 2009;38:281-290
  43. Tsukamoto K Suzuki H Harada D Namba A Abe S Usami S: Distribution and frequencies of PDS (SLC26A4) mutations in Pendred syndrome and nonsyndromic hearing loss associated with enlarged vestibular aqueduct: a unique spectrum of mutations in Japanese. Eur J Hum Genet 2003;11:916-922
  44. Wu CC Yeh TH Chen PJ Hsu CJ: Prevalent SLC26A4 mutations in patients with enlarged vestibular aqueduct and/or Mondini dysplasia: a unique spectrum of mutations in Taiwan, including a frequent founder mutation. Laryngoscope 2005;115:1060-1064
  45. Park HJ Lee SJ Jin HS, et al: Genetic basis of hearing loss associated with enlarged vestibular aqueducts in Koreans. Clin Genet 2005;67:160-165
  46. Dai P Li Q Huang D, et al: SLC26A4 c.919-2A>G varies among Chinese ethnic groups as a cause of hearing loss. Genet Med 2008;10:586-592
  47. Azaiez H Yang T Prasad S Sorensen JL Nishimura CJ Kimberling WJ Smith RJ: Genotype-phenotype correlations for SLC26A4-related deafness. Hum Genet 2007;122:451-457
  48. Scott DA Wang R Kreman TM Andrews M McDonald JM Bishop JR Smith RJH Karniski LP Sheffield VC: Functional differences of the PDS gene product are associated with phenotypic variation in patients with Pendred syndrome and non-syndromic hearing loss (DFNB4). Hum Mol Genet 2000;9:1709-1715
  49. Lopez-Bigas N Melchionda S de Cid R Grifa A Zelante L Govea N Arbones ML Gasparini P Estivill X: Identification of five new mutations of PDS/SLC26A4 in Mediterranean families with hearing impairment. Hum Mutat 2001;18:548
  50. Pera A Dossena S Rodighiero S Gandia M Botta G Meyer G Moreno F Nofziger C Hernandez-Chico C Paulmichl M: Functional assessment of allelic variants in the SLC26A4 gene involved in Pendred syndrome and nonsyndromic EVA. Proc Natl Acad Sci USA 2008;105:18608-18613
  51. Campbell C Cucci RA Prasad S Green GE Edeal JB Galer CE Karniski LP Sheffield VC Smith RJ: Pendred syndrome, DFNB4, and PDS/SLC26A4 identification of eight novel mutations and possible genotype-phenotype correlations. Hum Mutat 2001;17:403-411
  52. Pera A Villamar M Vinuela A Gandia M Meda C Moreno F Hernandez-Chico C: A mutational analysis of the SLC26A4 gene in Spanish hearing-impaired families provides new insights into the genetic causes of Pendred syndrome and DFNB4 hearing loss. Eur J Hum Genet 2008;16:888-896
  53. Pfarr N Borck G Turk A Napiontek U Keilmann A Muller-Forell W Kopp P Pohlenz J: Goitrous congenital hypothyroidism and hearing impairment associated with mutations in the TPO and SLC26A4/PDS genes. J Clin Endocrinol Metab 2006;91:2678-2681
  54. Kimberling WJ: Estimation of the frequency of occult mutations for an autosomal recessive disease in the presence of genetic heterogeneity: application to genetic hearing loss disorders. Hum Mutat 2005;26:462-470
  55. Yang T Vidarsson H Rodrigo-Blomqvist S Rosengren SS Enerback S Smith RJ: Transcriptional control of SLC26A4 is involved in Pendred syndrome and non-syndromic enlargement of vestibular aqueduct (DFNB4). Am J Hum Genet 2007;80:1055-1063
  56. Yang T Gurrola JG 2nd Wu H Chiu SM Wangemann P Snyder PM Smith RJ: Mutations of KCNJ10 together with mutations of SLC26A4 cause digenic nonsyndromic hearing loss associated with enlarged vestibular aqueduct syndrome. Am J Hum Genet 2009;84:651-657
  57. Wu CC Lu YC Chen PJ Yeh PL Su YN Hwu WL Hsu CJ: Phenotypic analyses and mutation screening of the SLC26A4 and FOXI1 genes in 101 Taiwanese families with bilateral nonsyndromic enlarged vestibular aqueduct (DFNB4) or Pendred syndrome. Audiol Neuro-Otol 2009;15:57-66
  58. Choi BY Alper SL Griffith AJ: Response to: The c.-103T>C variant in the 5'-UTR of SLC26A4 gene: a pathogenic mutation or coincidental polymorphism? Reply to Yang T, et al. [letter]. Hum Mutat 2009;30:1471Included with PubMed PMID 19787632
  59. Madden C Halsted M Meinzen-Derr J, et al: The influence of mutations in the SLC26A4 gene on the temporal bone in a population with enlarged vestibular aqueduct. Arch Otolar Head Neck Surg 2007;133:162-168
  60. Pryor SP Demmler GJ Madeo AC Yang Y Zalewski CK Brewer CC Butman JA Fowler KB Griffith AJ: Investigation of the role of congenital cytomegalovirus infection in the etiology of enlarged vestibular aqueducts. Arch Otolar Head Neck Surg 2005;131:388-392
  61. Loundon N Rouillon I Munier N Marlin S Roger G Garabedian EN: Cochlear implantation in children with internal ear malformations. Otol Neurotol 2005;26:668-673
  62. Papsin BC: Cochlear implantation in children with anomalous cochleovestibular anatomy. Laryngoscope 2005;115:(suppl 106)1-26
  63. Aschendorff A Marangos N Laszig R: Large vestibular aqueduct syndrome and its implication for cochlear implant surgery. Am J Otol 1997;18:(suppl 6)S57


Pay-per-View Options
Direct payment This item at the regular price: USD 33.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 23.00